ATARA BIOTHERAPEUTICS, INC. Stock Issued During Period, Shares, Period Increase (Decrease)
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, shares, period increase (decrease) for the quarter ending 2014-12-31 was 0.00 shares.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, shares, period increase (decrease) for fiscal 2014 was 1.30M shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) 3 month | Stock Issued During Period, Shares, Period Increase (Decrease) 12 month |
|---|---|---|
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | 1.30M shares 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |